Latest filing published 19 Oct 2026 for Elastic N.V..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -15.2%Entry US$113.25 · Close at T+365 US$96.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chetan Puttagunta: trading record in brief
This profile gathers the share dealings of Chetan Puttagunta across 4 companies, led by Elastic N.V., Confluent, Inc. and Aveo Pharmaceuticals, Inc. We count 18 filings; the first trade dates from 27 June 2018 and the latest from 15 October 2026.
Market trades split into 6 purchases (€821k) and 5 sales (€3.8M). Netting one side against the other leaves €3.0M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants.
A typical purchase (the median) is worth €98k. Of 6 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +29.0%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 19 October 2026, the filings show a share grant in Elastic N.V. The last insider purchase was made public on 1 April 2021, 2,047 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Chetan Puttagunta
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,519 shares0Ordinary SharesSEC:0001123292-26-001415:0
- 2,663 shares0Ordinary SharesSEC:0001123292-25-000505:0
- 2,666 shares0Ordinary SharesSEC:0001062993-24-017329:0
- 5,000 shares@ US$115.125100.0% of flowOrdinary SharesSEC:0001062993-23-022520:0
- 2,627 shares0Ordinary SharesSEC:0001062993-23-019204:0
- 2,627 shares0Ordinary SharesSEC:0001209191-22-053298:0
- 9,538 shares@ US$18.0084100.0% of flowClass A Common StockSEC:0001104659-22-090194:0
- 31,926 shares@ US$32.257632.0% of flowClass A Common StockSEC:0001104659-22-090199:0
- 100 shares@ US$75.640.2% of flowClass A Common StockSEC:0001104659-21-143955:1
- 31,826 shares@ US$75.082768.0% of flowClass A Common StockSEC:0001104659-21-143955:0
- 1,323 shares0Ordinary SharesSEC:0001209191-21-059616:0
- 1,000 shares@ US$115.019.5% of flowOrdinary SharesSEC:0001209191-21-024213:0Canonical exit: 10 Jun 2021 (T+90)
- 1,000 shares@ US$119.059.9% of flowOrdinary SharesSEC:0001209191-21-024213:1Canonical exit: 14 Jun 2021 (T+90)
- 1,000 shares@ US$110.669.3% of flowOrdinary SharesSEC:0001209191-21-024213:2Canonical exit: 23 Jun 2021 (T+90)
- 2,000 shares@ US$106.6918.1% of flowOrdinary SharesSEC:0001209191-21-024213:3Canonical exit: 28 Jun 2021 (T+90)
- 1,487 shares0Ordinary SharesSEC:0001209191-20-055615:0
- 187,130 shares@ US$2.1097.2% of flowCommon StockSEC:0001209191-18-039965:1Canonical exit: 26 Sept 2018 (T+90)
- ▲
Same trade as the filing by Growth Equity Opportunities IV, LLC, counted once
11,384 USD23SEC5,295 shares@ US$2.152.8% of flowCommon StockSEC:0001209191-18-039965:0Canonical exit: 25 Sept 2018 (T+90)
18 of 17 declarations
